These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
830 related items for PubMed ID: 26800524
1. Effects of Subinhibitory Concentrations of Ceftaroline on Methicillin-Resistant Staphylococcus aureus (MRSA) Biofilms. Lázaro-Díez M, Remuzgo-Martínez S, Rodríguez-Mirones C, Acosta F, Icardo JM, Martínez-Martínez L, Ramos-Vivas J. PLoS One; 2016; 11(1):e0147569. PubMed ID: 26800524 [Abstract] [Full Text] [Related]
2. Characterization of methicillin-resistant Staphylococcus aureus displaying increased MICs of ceftaroline. Mendes RE, Tsakris A, Sader HS, Jones RN, Biek D, McGhee P, Appelbaum PC, Kosowska-Shick K. J Antimicrob Chemother; 2012 Jun; 67(6):1321-4. PubMed ID: 22398650 [Abstract] [Full Text] [Related]
3. Mupirocin at Subinhibitory Concentrations Induces Biofilm Formation in Staphylococcus aureus. Sritharadol R, Hamada M, Kimura S, Ishii Y, Srichana T, Tateda K. Microb Drug Resist; 2018 Nov; 24(9):1249-1258. PubMed ID: 29653478 [Abstract] [Full Text] [Related]
4. Susceptibility patterns of Staphylococcus aureus biofilms in diabetic foot infections. Mottola C, Matias CS, Mendes JJ, Melo-Cristino J, Tavares L, Cavaco-Silva P, Oliveira M. BMC Microbiol; 2016 Jun 23; 16(1):119. PubMed ID: 27339028 [Abstract] [Full Text] [Related]
6. Evaluation of Ceftaroline Alone and in Combination against Biofilm-Producing Methicillin-Resistant Staphylococcus aureus with Reduced Susceptibility to Daptomycin and Vancomycin in an In Vitro Pharmacokinetic/Pharmacodynamic Model. Barber KE, Smith JR, Ireland CE, Boles BR, Rose WE, Rybak MJ. Antimicrob Agents Chemother; 2015 Aug 02; 59(8):4497-503. PubMed ID: 25987623 [Abstract] [Full Text] [Related]
7. Biofilm formation and dispersal of Staphylococcus aureus under the influence of oxacillin. Mirani ZA, Aziz M, Khan MN, Lal I, Hassan NU, Khan SI. Microb Pathog; 2013 Aug 02; 61-62():66-72. PubMed ID: 23711963 [Abstract] [Full Text] [Related]
8. Activity analyses of staphylococcal isolates from pediatric, adult, and elderly patients: AWARE Ceftaroline Surveillance Program. Sader HS, Flamm RK, Farrell DJ, Jones RN. Clin Infect Dis; 2012 Sep 02; 55 Suppl 3():S181-6. PubMed ID: 22903950 [Abstract] [Full Text] [Related]
9. Antimicrobial activity of ceftaroline against methicillin-resistant Staphylococcus aureus (MRSA) isolates collected in 2013-2014 at the Geneva University Hospitals. Andrey DO, François P, Manzano C, Bonetti EJ, Harbarth S, Schrenzel J, Kelley WL, Renzoni A. Eur J Clin Microbiol Infect Dis; 2017 Feb 02; 36(2):343-350. PubMed ID: 27744604 [Abstract] [Full Text] [Related]
10. A multicentre study of meticillin-resistant Staphylococcus aureus in acute bacterial skin and skin-structure infections in China: susceptibility to ceftaroline and molecular epidemiology. Zhang H, Xiao M, Kong F, O'Sullivan MV, Mao LL, Zhao HR, Zhao Y, Wang H, Xu YC. Int J Antimicrob Agents; 2015 Apr 02; 45(4):347-50. PubMed ID: 25649348 [Abstract] [Full Text] [Related]
11. In vitro activity of ceftaroline: A novel antibiotic against methicillin-resistant Staphylococcus aureus. Gaikwad V, Gohel T, Panickar S, Chincholkar V, Mangalkar S. Indian J Pathol Microbiol; 2016 Apr 02; 59(4):496-498. PubMed ID: 27721280 [Abstract] [Full Text] [Related]
12. In vitro evaluation of ceftaroline alone and in combination with tobramycin against hospital-acquired meticillin-resistant Staphylococcus aureus (HA-MRSA) isolates. Vidaillac C, Leonard SN, Rybak MJ. Int J Antimicrob Agents; 2010 Jun 02; 35(6):527-30. PubMed ID: 20346632 [Abstract] [Full Text] [Related]
13. Activity of ceftaroline against extracellular (broth) and intracellular (THP-1 monocytes) forms of methicillin-resistant Staphylococcus aureus: comparison with vancomycin, linezolid and daptomycin. Mélard A, Garcia LG, Das D, Rozenberg R, Tulkens PM, Van Bambeke F, Lemaire S. J Antimicrob Chemother; 2013 Mar 02; 68(3):648-58. PubMed ID: 23188792 [Abstract] [Full Text] [Related]
14. The effectiveness of anti-biofilm and anti-virulence properties of dihydrocelastrol and dihydrocelastryl diacetate in fighting against methicillin-resistant Staphylococcus aureus. Woo SG, Lee SM, Lee SY, Lim KH, Ha EJ, Kim SH, Eom YB. Arch Microbiol; 2017 Oct 02; 199(8):1151-1163. PubMed ID: 28487997 [Abstract] [Full Text] [Related]
15. Antimicrobial Activity of Ceftaroline Tested against Staphylococcus aureus from Surgical Skin and Skin Structure Infections in US Medical Centers. Sader HS, Farrell DJ, Flamm RK, Jones RN. Surg Infect (Larchmt); 2016 Aug 02; 17(4):443-7. PubMed ID: 26990170 [Abstract] [Full Text] [Related]
16. Potential of Staphylococcus aureus isolates carrying different PBP2a alleles to develop resistance to ceftaroline. Lahiri SD, Alm RA. J Antimicrob Chemother; 2016 Jan 02; 71(1):34-40. PubMed ID: 26483514 [Abstract] [Full Text] [Related]
17. Effects of sub-inhibitory concentrations of nafcillin, vancomycin, ciprofloxacin, and rifampin on biofilm formation of clinical methicillin-resistant Staphylococcus aureus. Park K-H, Kim D, Jung M, Kim DY, Lee Y-M, Lee MS, Hong K-W, Bae I-G, Hong SI, Cho O-H. Microbiol Spectr; 2024 Jun 04; 12(6):e0341223. PubMed ID: 38651875 [Abstract] [Full Text] [Related]
18. Effect of stress on biofilm formation by icaA positive and negative strains of methicillin resistant Staphylococcus aureus. Mirani ZA, Khan MN, Aziz M, Asadullah, Naz S, Khan SI. J Coll Physicians Surg Pak; 2012 Jan 04; 22(1):10-4. PubMed ID: 22237182 [Abstract] [Full Text] [Related]
19. Eugenol: a phyto-compound effective against methicillin-resistant and methicillin-sensitive Staphylococcus aureus clinical strain biofilms. Yadav MK, Chae SW, Im GJ, Chung JW, Song JJ. PLoS One; 2015 Jan 04; 10(3):e0119564. PubMed ID: 25781975 [Abstract] [Full Text] [Related]
20. [In vitro activity of ceftaroline against Spanish isolates of Staphylococcus aureus: a multicenter study]. Tenorio-Abreu A, Gil Tomás J, Bratos Pérez MÁ, de la Iglesia Salgado A, Borrás Máñez M, Ortiz de Lejarazu Leonardo R, Ávila Alonso A, Colomina Rodríguez J, Pérez Cáceres JA, Saavedra Martín JM, Márquez Sanabria A, Domínguez Castaño A, de la Iglesia Salgado M. Enferm Infecc Microbiol Clin; 2015 Feb 04; 33(2):101-4. PubMed ID: 25091384 [Abstract] [Full Text] [Related] Page: [Next] [New Search]